Experiments for taxon Celastrus orbiculatus (CELASTRACEAE)

Experiments (209 results)

209 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
658251	VOUCHER SPECIMEN REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)
1233522	QUANTITATIVE DATAIDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	PROTEIN
277464	PHARMACOLOGY OF COMPOUND - IN VITRO	NUCLEAR FACTOR KAPPA-BETA INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN E
638130	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLOOXYGENASE 1 INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	AFZELECHIN,EPI: (-):
233613	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN B
1310786	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: 1S,4R,5S,6R,7R,8R,9S,10S)-6-8-DIACETOXY-9-BENZOYLOXY-1-HYDROXY :
277455	PHARMACOLOGY OF COMPOUND - IN VITRO	NUCLEAR FACTOR KAPPA-BETA INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN I
212649	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
212650	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
181511	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-ACETOXY-9-ALPHA-CINNAMOYL-OXY:
212667	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
233615	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN B
277474	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	CELAPHANOL A
233618	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN C
406540	X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMORD SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENT		Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL,ISO:CELORBICOL
233629	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN F
1310801	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN B-3
354266	PHARMACOLOGY OF EXTRACT - IN VITRO	ANGIOTENSIN-II INHIBITION	Celastrus orbiculatus (CELASTRACEAE)
212646	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
277466	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN F
1321173	PHARMACOLOGY OF EXTRACT - IN VIVO	NOCICEPTIVE RESPONSE REDUCTION	Celastrus orbiculatus (CELASTRACEAE)
277469	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	CELASTROL
658266	PHARMACOLOGY OF EXTRACT - IN VITRO	HISTAMINE-1 RECEPTOR BINDING ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
277450	VOUCHER SPECIMEN REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)
638127	PHARMACOLOGY OF EXTRACT - IN VITRO	CYCLOOXYGENASE 1 INHIBITION	Celastrus orbiculatus (CELASTRACEAE)
1310797	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: 1-BETA-ACETOXY-9-ALPHA-CINNAMYLOXY:AGAROFURAN,BETA: DIHYDRO: 9-ALPHA-ACETOXY-1-6-ALPHA-DIBENZOYLOXY:
658261	PHARMACOLOGY OF EXTRACT - IN VITRO	CALCIUM CHANNEL BINDING EFFECT	Celastrus orbiculatus (CELASTRACEAE)
1310785	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: (1S,4R,5S,6R,7R,8R,9S,10S)-6-ACETOXY-1-9-DIBENZOYLOXY-8-BUTYRYLOXY:
301248	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)	OLEAN-12-EN-28-OIC ACID,24-HYDROXY-3-OXO:
1310796	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)
707570	PHARMACOLOGY OF EXTRACT - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Celastrus orbiculatus (CELASTRACEAE)
1310795	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN C-1
277463	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN E
571329	VOUCHER SPECIMEN REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)
658267	PHARMACOLOGY OF EXTRACT - IN VITRO	ATP-ASE (NA+/K+) BINDING ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
1310805	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN B-1
277454	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN I
233645	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-6-ALPHA-15-TRIACETOXY-20-BETA-9-ALPHA-DIBENZOYL-OXY:
233637	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	TRIPTOGELIN C-1
658262	PHARMACOLOGY OF EXTRACT - IN VITRO	SULFONYLUREA RECEPTOR BLOCKING EFFECT	Celastrus orbiculatus (CELASTRACEAE)
1321172	PHARMACOLOGY OF EXTRACT - IN VIVO	NOCICEPTIVE RESPONSE REDUCTION	Celastrus orbiculatus (CELASTRACEAE)
212673	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL ESTER
1306038	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	CELAXANTHIN,(CIS 3', CIS 5')TORULENE,(TRANS 3', TRANS 5')
212662	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
609957	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	PRISTIMERIN
277471	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	CELASTROL
212684	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL ESTER
1310792	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: (1S,4S,5S,6R,7R,9S,10S)-1-ACETOXY-6-9-DIBENZOYLOXY-14-HYDROXY:
1093462	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE	ANTIVIRAL ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELASTRUS ORBICULATUS SUBSTANCE C-7
726606	PHARMACOLOGY OF EXTRACT - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
212659	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
233626	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN E
1310809	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN C-1AGAROFURAN,BETA: DIHYDRO: (1S,4R,5S,6R,7R,8R,9S,10S)-6-ACETOXY-9-BENZOYLOXY-1-CINNAMYLOXY-8-HYDROXY:AGAROFURAN,BETA: DIHYDRO: 1-BETA-ACETOXY-9-ALPHA-CINNAMYLOXY:AGAROFURAN,BETA: DIHYDRO: (1S,4R,5S,6R,7R,8R,9S,10S)-6-ACETOXY-1-9-DIBENZOYLOXY-8-BUTYRYLOXY:AGAROFURAN,BETA: DIHYDRO: 9-ALPHA-ACETOXY-1-6-ALPHA-DIBENZOYLOXY:AGAROFURAN,BETA: DIHYDRO: 2-ALPHA-9-BETA-DIACETOXY-1-ALPHA-CINNAMYLOXY:AGAROFURAN,BETA: DIHYDRO: 6-BETA-ACETOXY-1-ALPHA-8-ALPHA-DIBENZOYLOXY-9-ALPHA-HYDROXY:CELAFOLIN A-1
277458	PHARMACOLOGY OF COMPOUND - IN VITRO	NUCLEAR FACTOR KAPPA-BETA INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN A
212657	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
212678	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL ESTER
384870	VOUCHER SPECIMEN REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)
1310808	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
277456	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN I
233634	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN G
571330	MEDICINAL FOLKLORE REPORTED FOR	FOOD USE	Celastrus orbiculatus (CELASTRACEAE)
212668	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
233623	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN D
1310798	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: 2-ALPHA-9-BETA-DIACETOXY-1-ALPHA-CINNAMYLOXY:
1085645	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NEMATOCIDAL ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
21616	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)SEPARATION OF (EXCEPT OILS, VENOM, PROTEINS, FATS)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIBACTERIAL ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELASTRUS PANICULATUS SUBSTANCE(MP 190)
963141	CRUDE DRUG DESCRIPTIONMICROSCOPY OF		Celastrus orbiculatus (CELASTRACEAE)
277465	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN E
21394	PHYTOCHEMICAL SCREENING FORVOUCHER SPECIMEN REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)	O
277460	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN D
658255	PHARMACOLOGY OF EXTRACT - IN VITRO	CA PUMP INHIBITION	Celastrus orbiculatus (CELASTRACEAE)
212645	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
1233521	LIPID ANALYSIS REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)
277452	PHARMACOLOGY OF COMPOUND - IN VITRO	NUCLEAR FACTOR KAPPA-BETA INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN H
658263	PHARMACOLOGY OF EXTRACT - IN VITRO	RECEPTOR BINDING(DOPAMINE) DECREASED	Celastrus orbiculatus (CELASTRACEAE)
1310802	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: 6-BETA-9-BETA-DIACETOXY-1ALPHA-BENZOYLOXY:
212648	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
1321176	PHARMACOLOGY OF EXTRACT - IN VIVO	SLEEP TIME INCREASED	Celastrus orbiculatus (CELASTRACEAE)
638131	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AFZELECHIN,EPI: (-):
1310787	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: (1S,4R,5S,6R,7R,8R,9S,10S)-6-ACETOXY-9-BENZOYLOXY-1-8-DIHYDROXY:
212661	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
233644	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	EJAP 2
658259	PHARMACOLOGY OF EXTRACT - IN VITRO	ADENOSINE RECEPTOR BINDING INHIBITION	Celastrus orbiculatus (CELASTRACEAE)
212660	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
233612	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN B
212672	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL ESTER
1093461	QUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	DULCITOL
658258	PHARMACOLOGY OF EXTRACT - IN VITRO	OPIATE RECEPTOR BINDING INHIBITION	Celastrus orbiculatus (CELASTRACEAE)
212651	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
658252	PHARMACOLOGY OF EXTRACT - IN VITRO	ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
277459	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN A
212679	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL ESTER
1310791	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: 1-ALPHA-2-ALPHA-DIACETOXY-9-BETA-CINNAMYLOXY-4-BETA-HYDROXY:
1310794	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: 6-BETA-ACETOXY-1-ALPHA-8-ALPHA-9-ALPHA-TRIBENZOYLOXY:
233619	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN C
1306039	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	PHYTOENEVIOLAXANTHINLUTEINCELAXANTHINTORULENECRYPTOXANTHIN,BETA:PHYTOFLUENEANTHERAXANTHINCAROTENE,BETA:CAROTENE,GAMMA:NEOXANTHINZEAXANTHINRUBIXANTHIN
181510	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-BENZOYL-OXY-9-ALPHA-CINNAMOYL-OXY:AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-9-ALPHA-CIS-CINNAMOYL-OXY:
277453	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN H
212656	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
212683	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL ESTER
339098	GC DATA REPORTEDPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	MALKANGUNIOL
212669	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
233633	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	TRIPTOGELIN C-1
609955	ISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	TRIACONTAN-1-OL ACETATEAMYRIN,BETA:PRISTIMERINAMYRIN,BETA: PALMITATESITOSTEROL,BETA:
1321170	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
638126	VOUCHER SPECIMEN REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)
233622	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN D
233640	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	EJAP 2
212682	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL ESTER
1310788	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: (1S,4R,5S,6R,7R,8R,9S,10S)-1-8-9-TRIBENZOYLOXY-6-HYDROXY:
233625	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN F
212644	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
277468	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN F
1310807	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)
406542	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREYIELD IS LESS THAN 50 MGM		Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL,1-2-DIBENZOYL-9-ACETYL:CELORBICOL,ISO: 1-BENZOYL-2-6-9-TRIACETYL:
1321175	PHARMACOLOGY OF EXTRACT - IN VIVO	NOCICEPTIVE RESPONSE REDUCTION	Celastrus orbiculatus (CELASTRACEAE)
233647	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-6-ALPHA-15-TRIACETOXY-20-BETA-9-ALPHA-DIBENZOYL-OXY:
212665	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
658264	PHARMACOLOGY OF EXTRACT - IN VITRO	RECEPTOR BINDING(DOPAMINE) DECREASED	Celastrus orbiculatus (CELASTRACEAE)
442010	PHARMACOLOGY OF EXTRACT - IN VITRO	PROTEIN KINASE C INHIBITION	Celastrus orbiculatus (CELASTRACEAE)
638129	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	AFZELECHIN,EPI: (-):
212671	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
1310799	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: 6-BETA-ACETOXY-1-ALPHA-8-ALPHA-DIBENZOYLOXY-9-ALPHA-HYDROXY:
277451	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN H
1310803	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: 1-ALPHA-6-ALPHA-14-TRIACETOXY-9-BETA-BENZOYLOXY:
212676	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL ESTER
277461	PHARMACOLOGY OF COMPOUND - IN VITRO	NUCLEAR FACTOR KAPPA-BETA INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN D
1277822	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 6-ALPHA-13-BETA-DIACETOXY-1-BETA-8-BETA-9-BETA-TRIBENZOYL-OXY:
1139005	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMUTAGENIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
1310800	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
212670	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
233643	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	EJAP 2
212655	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
604781	MEDICINAL FOLKLORE REPORTED FOR	ANTITUMOR ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
212675	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL ESTER
281512	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-ALPHA-ACETOXY-2-ALPHA-HYDROXY-9-BETA-CINNAMOYL-OXY:AGAROFURAN,BETA-DIHYDRO: 1-ALPHA-6-BETA-DIACETOXY-9-BETA-BENZOYL-OXY:AGAROFURAN,BETA-DIHYDRO: 1-ALPHA-6-BETA-DIACETOXY-9-BETA-CINNAMOYL-OXY:AGAROFURAN,BETA-DIHYDRO: 1-ALPHA-2-ALPHA-DIACETOXY-9-BETA-CINNAMOYL-OXY:AGAROFURAN,BETA-DIHYDRO: 1-ALPHA-HYDROXY-2-ALPHA-ACETOXY-9-BETA-CINNAMOYL-OXY:AGAROFURAN,BETA-DIHYDRO: 1-ALPHA-ACETOXY-6-BETA-9-BETA-DIBENZOYL-OXY:
1310790	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: (1R,2S,4R,5S,6R,7R,9S,10R)-1-6-DIACETOXY-9-CINNAMYLOXY-2-HYDROXY:
233632	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN G
726604	VOUCHER SPECIMEN REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)
658257	PHARMACOLOGY OF EXTRACT - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Celastrus orbiculatus (CELASTRACEAE)
212652	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
1092434	PHARMACOLOGY OF EXTRACT - IN VITROPLANT TISSUE CULTURE MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
277472	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	CELAPHANOL A
21618	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)SEPARATION OF (EXCEPT OILS, VENOM, PROTEINS, FATS)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIBACTERIAL ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELASTRUS PANICULATUS SUBSTANCE(MP 190)
212664	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
658253	PHARMACOLOGY OF EXTRACT - IN VITRO	ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
209353	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-ALPHA-2-ALPHA-8-BETA-TRIACETOXY-9-BETA-CINNAMOYL-OXY:
233621	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN D
908526	PHYTOCHEMICAL SCREENING FOR		Celastrus orbiculatus (CELASTRACEAE)	OO
658269	PHARMACOLOGY OF EXTRACT - IN VITRO	GABA RECEPTOR BLOCKING EFFECT	Celastrus orbiculatus (CELASTRACEAE)
233624	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN E
233617	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN D
233616	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN C
658260	PHARMACOLOGY OF EXTRACT - IN VITRO	RECEPTOR BINDING(BENZODIAZEPINE) DECREASED	Celastrus orbiculatus (CELASTRACEAE)
406541	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL,1-BENZOYL-6-9-DIACETYL:
212681	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL ESTER
212658	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
233614	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN B
638128	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
277473	PHARMACOLOGY OF COMPOUND - IN VITRO	NUCLEAR FACTOR KAPPA-BETA INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	CELAPHANOL A
1321746	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	NOCICEPTIVE RESPONSE REDUCTION	Celastrus orbiculatus (CELASTRACEAE)
609956	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	PRISTIMERIN
1310793	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: (1S,4R,5S,6R,7R,9S,10S)-1-ACETOXY-9-BENZOYLOXY-6-HYDROXY:
277457	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN A
1092435	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
233641	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-6-ALPHA-15-TRIACETOXY-20-BETA-9-ALPHA-DIBENZOYL-OXY:
233635	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN G
658265	PHARMACOLOGY OF EXTRACT - IN VITRO	MUSCARINIC RECEPTOR BINDING ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
1310804	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	TRIPTOGELIN B-1
1139004	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMUTAGENIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
277467	PHARMACOLOGY OF COMPOUND - IN VITRO	NUCLEAR FACTOR KAPPA-BETA INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN F
1321174	PHARMACOLOGY OF EXTRACT - IN VIVO	NOCICEPTIVE RESPONSE REDUCTION	Celastrus orbiculatus (CELASTRACEAE)
604782	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
233628	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN E
212666	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
233639	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	TRIPTOGELIN C-1
233646	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-6-ALPHA-15-TRIACETOXY-20-BETA-9-ALPHA-DIBENZOYL-OXY:
212677	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL ESTER
233630	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN F
1321171	PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR	NOCICEPTIVE RESPONSE REDUCTION	Celastrus orbiculatus (CELASTRACEAE)
21617	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)SEPARATION OF (EXCEPT OILS, VENOM, PROTEINS, FATS)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIBACTERIAL ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELASTRUS PANICULATUS SUBSTANCE(MP 190)
658268	PHARMACOLOGY OF EXTRACT - IN VITRO	GABA RECEPTOR BLOCKING EFFECT	Celastrus orbiculatus (CELASTRACEAE)
212680	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL ESTER
791413	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	CYCLOOXYGENASE INHIBITION	Celastrus orbiculatus (CELASTRACEAE)
707571	PHARMACOLOGY OF EXTRACT - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Celastrus orbiculatus (CELASTRACEAE)
277462	PHARMACOLOGY OF COMPOUND - IN VITRO	NITRIC OXIDE SYNTHESIS INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN D
43125	ISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	SUCROSE
384871	PHARMACOLOGY OF EXTRACT - IN VITRO	TYROSINASE INHIBITION	Celastrus orbiculatus (CELASTRACEAE)
658256	PHARMACOLOGY OF EXTRACT - IN VITRO	SEROTONIN (5-HT) RECEPTOR BLOCKING EFFECT	Celastrus orbiculatus (CELASTRACEAE)
212647	PHARMACOLOGY OF COMPOUND - IN VITRO	MULTIDRUG RESISTANCE INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
212653	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
1310806	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: 6-BETA-ACETOXY-8-ALPHA-9-ALPHA-DIBENZOYLOXY-1-ALPHA-2-ALPHA-DIHYDROXY:
233642	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	EJAP 2
233638	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	TRIPTOGELIN C-1
209354	IDENTIFICATION IN BY GC/MS		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-ALPHA-6-BETA-DIACETOXY-9-BETA-BENZOYL-OXY:AGAROFURAN,BETA-DIHYDRO: 1-ALPHA-ACETOXY-6-BETA-9-BETA-DIBENZOYL-OXY:
233620	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN C
212674	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELORBICOL ESTER
908527	PHYTOCHEMICAL SCREENING FOR		Celastrus orbiculatus (CELASTRACEAE)	OOO
277470	PHARMACOLOGY OF COMPOUND - IN VITRO	NUCLEAR FACTOR KAPPA-BETA INHIBITION	Celastrus orbiculatus (CELASTRACEAE)	CELASTROL
21615	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)SEPARATION OF (EXCEPT OILS, VENOM, PROTEINS, FATS)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTIBACTERIAL ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELASTRUS PANICULATUS SUBSTANCE(MP 190)
1310789	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA: DIHYDRO: (1S,4R,5S,6R,7R,8R,9S,10S)-6-ACETOXY-9-BENZOYLOXY-1-CINNAMYLOXY-8-HYDROXY:
212654	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	AGAROFURAN,BETA-DIHYDRO: 1-BETA-2-BETA-DIACETOXY-6-ALPHA-9-ALPHA-BIS-(BENZOYL-OXY):
726605	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIADHESION EFFECT	Celastrus orbiculatus (CELASTRACEAE)
233627	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN E
233636	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN G
212663	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	CELAFOLIN A-1
658254	PHARMACOLOGY OF EXTRACT - IN VITRO	ADRENERGIC(ALPHA-2) RECEPTOR BINDING ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)
1242696	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OF		Celastrus orbiculatus (CELASTRACEAE)	QUERCETIN-3-O-BETA-D-GLUCOSYL-7-O-ALPHA-L-RHAMNOSIDEKAEMPFEROL-3-O-BETA-D-GLUCOSYL-7-ALPHA-L-RHAMNOSIDEKAEMPFEROL-3-7-O-ALPHA-L-DIRHAMNOSIDEQUERCETIN-3-7-DI-O-ALPHA-L-RHAMNOSIDEKAEMPFEROL-7-O-ALPHA-L-RHAMNOSIDE
233631	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Celastrus orbiculatus (CELASTRACEAE)	ORBICULIN F

Experiments for taxon Celastrus orbiculatus (CELASTRACEAE)

Experiments (209 results)

Filters

Worktypes (33)

Pharmacology (33)

Compounds (92)

Organisms (36)